Product Datasheet
|
|
| |
| Product Description |
| |
| Product: |
IgG4, Human Myeloma Plasma |
| Catalog Number: |
HU-IGG4M |
| Product Page: |
https://www.mol-innov.com/products/ |
| Description: |
IgG4 antibodies will dominate the IgG response in schistosomiasis, lymphatic filariasis, and in patients after allergen immunotherapy. Unlike the other IgG subclasses, IgG4 does not activate complement. A combined IgA-IgG4 deficiency has been associated with recurrent pyogenic infections. Prepared from myeloma plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. |
| Recommended Storage: |
SAMPLE |
| Minimum Shelf Life: |
408.50 |
| Source: |
1.0 mg/ml |
| Molecular Weight: |
Proteins |
| Extinction Coefficient: |
146,000 |
| Antigen: |
-70 C |
| Target: |
Frozen liquid |
| Target Molecular Weight: |
HUMAN IMMUNOGLOBULINS |
| Host: |
1629.25 |
| Clonality: |
5 |
| Isotype: |
Human myeloma plasma |
| Clone: |
s |
| Applications: |
Dry ice |
| Cross-reactivity: |
3 years from delivery |
| Concentration: |
430 |
| Volume: |
1715 |
| Specific activity: |
SodiumAzide |
| Titer: |
0.02M Sodium Phosphate; 0.15M NaCl; 0.05% Azide; pH 7.4 |
| Buffer: |
SAMPLE |
| Form: |
1.0 mg |
| Preservative: |
1.0 ml |
| |
| Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
| |
| For in vitro laboratory use only |
| |
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |